IP Library Granted Patent US 7,132,235
Granted Patent B2
US 7,132,235 · App. 08/465,322 · Granted Nov 7, 2006

Reagent kit for determining specific nucleotide variations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,132,235
App. No.
08/465,322
Granted
Nov 7, 2006
Kind
B2
Abstract

Detection of variable nucleotide(s) is based on primer extension and incorporation of detectable nucleoside triphosphates. By selecting the detection step primers from the region immediately adjacent to the variable nucleotide, this variation can be detected after incorporation of as few as one nucleoside triphosphate. Labelled nucleoside triphosphates matching the variable nucleotide are added and the incorporation of a label into the detection step primer is measured. The selection of the detection step primer is important to the method according to this invention and is dependent on the nucleotide sequence of interest. The detection step primers are preferably selected so as to span the region immediately toward the 3′ end from the variable nucleotide to be detected. The detection step primers can also be complementary to a sequence beginning several nucleotides removed from the variable nucleotide. The only limitation concerning the position of the detection step primers is that the sequence between the 3′ end of the detection step primer and the variable nucleotide to be detected must not contain a nucleotide residue of the same type as the one to be detected. The detection step primers can equally well be chosen to be complementary to either the coding or non-coding strands of the nucleotide sequence of interest.

Claims (36)

1. A reagent kit for detecting the presence or absence of one or more specific nucleotides at a predetermined target position in a target nucleic-acid polymer, comprising:

(a) a detection primer comprising a detection-primer nucleotide sequence having a primer-extension-initiation 3′-end nucleotide which constitutes a 3′ terminal end of the detection primer, the detection-primer nucleotide sequence being complementary to a primer-hybridizing nucleotide sequence of the target nucleic-acid polymer with a nucleotide in the target nucleic-acid polymer complementary to the primer-extension-initiation 3′-end nucleotide of the detection-primer nucleotide sequence defining a primer-end complement nucleotide, the primer-hybridizing nucleotide sequence of the target nucleic-acid polymer extending towards the 3′ end of the target polymer from the primer-end complement nucleotide, the primer-end complement nucleotide being located in the target polymer at a position 3′-ward of the predetermined target position, the position of the primer-end complement nucleotide being subject to a constraint that no nucleotide of the same type as the one or more specific nucleotides to be detected be located in the target polymer in any position between the position of the primer-end complement nucleotide and the predetermined target position;

(b) an enzymatic polymerizing agent; and

(c) a plurality of nucleoside triphosphates including at least one deoxynucleotide and at least two different chain-terminating nucleotide analogues, at least one deoxynucleotide comprising a detectable label or an attachment moiety capable of binding a detectable label, each deoxynucleotide of said plurality of nucleoside triphosphates being complementary to a nucleotide which differs from any nucleotide to which a chain-terminating nucleotide analogue of said plurality of nucleoside triphosphates is complementary;

so that in use the detection primer can hybridize to the target nucleic-acid polymer at the primer-hybridizing nucleotide sequence and form a detection-primer extension product by an enzyme-catalyzed primer-extension reaction to permit the presence or absence of a specific nucleotide at the predetermined target position to be detected by detecting the presence or absence of a corresponding detectable label in association with the detection-primer extension product.

2. A reagent kit according to claim 1 wherein the detection primer comprises an attachment moiety.

3. A reagent kit according to claim 1 wherein the detection-primer nucleotide sequence is from 10 to 40 nucleotides in length.

4. A reagent kit according to claim 1 wherein each chain-terminating nucleotide analogue of the nucleoside triphosphates of paragraph (c) is a dideoxyribonucleotide selected from the group consisting of ddATP, ddGTP, ddCTP, and ddTTP.

5. A reagent kit according to claim 1 wherein the nucleoside triphosphates of paragraph (c) include at least two deoxynucleotides, at least one of which deoxynucleotide comprises a detectable label or an attachment moiety capable of binding a detectable label.

6. A reagent kit according to claim 1 wherein each deoxynucleotide of the nucleoside triphosphates of paragraph (c) is a deoxyribonucleoside triphosphate selected from the group consisting of dATP, dGTP, dCTP, dUTP, and dTTP.

7. A reagent kit according to claim 1 in which the primer-end complement nucleotide is located in the target nucleic-acid polymer at a position immediately adjacent to the predetermined target position.

8. A reagent kit according to claim 1 in which the detectable label is a radioisotope.

9. A reagent kit according to claim 1 further comprising:

(d) a pair of amplification primers for amplifying the target nucleic-acid polymer, the two amplification primers bracketing the predetermined target position in the target polymer, at least one of the amplification primers comprising an attachment moiety for immobilizing target nucleic-acid polymer molecules on a solid support.

10. A reagent kit according to claim 9 further comprising:

(e) a solid support.

11. A reagent kit for detecting the presence or absence of one or more specific nucleotides at a predetermined target position in a target nucleic-acid polymer, comprising:

(a) a detection primer comprising a detection-primer nucleotide sequence having a primer-extension-initiation 3′-end nucleotide which constitutes a 3′ terminal end of the detection primer, the detection-primer nucleotide sequence being complementary to a primer-hybridizing nucleotide sequence of the target nucleic-acid polymer with a nucleotide in the target nucleic-acid polymer complementary to the primer-extension-initiation 3′-end nucleotide of the detection-primer nucleotide sequence defining a primer-end complement nucleotide, the primer-hybridizing nucleotide sequence of the target nucleic-acid polymer extending towards the 3′ end of the target polymer from the primer-end complement nucleotide, the primer-end complement nucleotide being located in the target polymer at a position 3′-ward of the predetermined target position, the position of the primer-end complement nucleotide being subject to a constraint that no nucleotide of the same type as the one or more specific nucleotides to be detected be located in the target polymer in any position between the position of the primer-end complement nucleotide and the predetermined target position;

(b) an enzymatic polymerizing agent; and

(c) a plurality of nucleoside triphosphates including at least one deoxynucleotide and at least one chain-terminating nucleotide analogue, at least one chain-terminating nucleotide analogue comprising a detectable label or an attachment moiety capable of binding a detectable label, each deoxynucleotide of said plurality of nucleoside triphosphates being complementary to a nucleotide which differs from any nucleotide to which a chain-terminating nucleotide analogue of said plurality of nucleoside triphosphates is complementary;

so that in use the detection primer can hybridize to the target nucleic-acid polymer at the primer-hybridizing nucleotide sequence and form a detection-primer extension product by an enzyme-catalyzed primer-extension reaction to permit the presence or absence of a specific nucleotide at the predetermined target position to be detected by detecting the presence or absence of a corresponding detectable label in association with the detection-primer extension product.

12. A reagent kit according to claim 11 wherein the detection primer comprises an attachment moiety.

13. A reagent kit according to claim 11 wherein the detection-primer nucleotide sequence is from 10 to 40 nucleotides in length.

14. A reagent kit according to claim 11 wherein each chain-terminating nucleotide analogue of the nucleoside triphosphates of paragraph (c) is a dideoxyribonucleotide selected from the group consisting of ddATP, ddGTP, ddCTP, and ddTTP.

15. A reagent kit according to claim 14 in which at least one dideoxyribonucleotide of the nucleoside triphosphates of paragraph (c) comprises a detectable label consisting of a fluorescent group.

16. A reagent kit according to claim 11 wherein the nucleoside triphosphates of paragraph (c) include at least two deoxynucleotides.

17. A reagent kit according to claim 11 wherein each deoxynucleotide of the nucleoside triphosphates of paragraph (c) is a deoxyribonucleoside triphosphate selected from the group consisting of dATP, dGTP, dCTP, dUTP, and dTTP.

18. A reagent kit according to claim 11 in which the primer-end complement nucleotide is located in the target nucleic-acid polymer at a position immediately adjacent to the predetermined target position.

19. A reagent kit according to claim 11 further comprising:

(d) a pair of amplification primers for amplifying the target nucleic-acid polymer, the two amplification primers bracketing the predetermined target position in the target polymer, at least one of the amplification primers comprising an attachment moiety for immobilizing target nucleic-acid polymer molecules on a solid support.

20. A reagent kit according to claim 19 further comprising:

(e) a solid support.

21. A reagent kit according to claim 1 in which the primer-end complement nucleotide is located in the target nucleic-acid polymer at a position spaced a plurality of nucleotides away from the predetermined target position.

22. A reagent kit according to claim 11 in which the primer-end complement nucleotide is located in the target nucleic-acid polymer at a position spaced a plurality of nucleotides away from the predetermined target position.

23. A reagent kit according to claim 1 in which said plurality of nucleoside triphosphates of the reagent kit are packaged as an admixture.

24. A reagent kit according to claim 11 in which said plurality of nucleoside triphosphates of the reagent kit are packaged as an admixture.

Assignments (4)
CHANGE OF NAME Recorded Oct 7, 2005
From: ORCHID BIOSCIENCES, INC.
To: ORCHID CELLMARK INC.
Reel/Frame 016851/0915 →
CHANGE OF NAME Recorded Mar 20, 2000
From: ORCHID BIOCOMPUTER, INC.
To: ORCHID BIOSCIENCES, INC.
Reel/Frame 010703/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 1999
From: MOLECULAR TOOL, INC.
To: ORCHID BIOCOMPUTER, INC.
Reel/Frame 009827/0127 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 1997
From: ORION CORPORATION LTD.
To: MOLECULAR TOOL, INC.
Reel/Frame 008806/0863 →